Wall Street Zen Upgrades Teleflex (NYSE:TFX) to "Hold"

Key Points

• Wall Street Zen upgraded Teleflex from “Sell” to “Hold,” joining a broader consensus “Hold” rating. Analysts’ consensus price target is $149.80, compared with the stock’s recent price of $134.50.
• Teleflex reported strong quarterly results, with revenue up 28.9% year over year to $570.3 million and EPS of $1.76, beating analyst expectations of $559.6 million and $1.28, respectively.
• Despite the earnings beat, profitability remains a concern: adjusted EPS declined from $3.73 a year earlier, GAAP EPS fell to $0.96, and the company posted a negative net margin. Institutional investors own approximately 95.6% of the shares.

Teleflex (NYSE:TFX - Get Free Report) was upgraded by analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Sunday.

A number of other equities research analysts also recently weighed in on the company. Bank of America raised Teleflex from an "underperform" rating to a "neutral" rating and set a $135.00 target price on the stock in a report on Monday, April 13th. Truist Financial restated a "hold" rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Mizuho lifted their target price on Teleflex from $140.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, July 15th. Weiss Ratings reissued a "sell (d)" rating on shares of Teleflex in a research note on Wednesday, June 24th. Finally, UBS Group initiated coverage on shares of Teleflex in a report on Tuesday, July 28th. They issued a "neutral" rating and a $145.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $149.80.

Teleflex Trading Down 3.2%

TFX opened at $134.50 on Friday. Teleflex has a twelve month low of $100.18 and a twelve month high of $145.00. The company has a 50-day simple moving average of $131.72 and a 200 day simple moving average of $122.54. The company has a quick ratio of 2.03, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $5.95 billion, a price-to-earnings ratio of -5.78, a P/E/G ratio of 0.95 and a beta of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The business's quarterly revenue was up 28.9% compared to the same quarter last year. During the same period last year, the firm earned $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Analysts predict that Teleflex will post 7.44 EPS for the current fiscal year.

Hedge Funds Weigh In On Teleflex

Large investors have recently bought and sold shares of the company. Hsbc Holdings PLC increased its stake in shares of Teleflex by 4.7% in the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company's stock valued at $222,000 after buying an additional 84 shares during the period. Banque Cantonale Vaudoise boosted its position in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock worth $31,000 after buying an additional 113 shares during the period. Hantz Financial Services Inc. boosted its position in Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company's stock worth $48,000 after buying an additional 113 shares during the period. UMB Bank n.a. grew its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock worth $38,000 after acquiring an additional 113 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its holdings in Teleflex by 1.5% during the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company's stock worth $1,056,000 after acquiring an additional 129 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Trending Headlines about Teleflex

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex announced a $250 million accelerated share repurchase agreement. The program should reduce the company’s share count and may support per-share earnings and investor sentiment. Teleflex Launches $250 Million Accelerated Share Repurchase
• Positive Sentiment: Second-quarter revenue rose 28.9% year over year to $570.3 million, exceeding the $559.6 million consensus estimate. Adjusted EPS of $1.76 also beat expectations of $1.28, providing evidence of better-than-expected operating performance. Teleflex Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Teleflex raised or reaffirmed its fiscal 2026 adjusted EPS outlook at $6.90 to $7.20, above the $6.70 analyst consensus. Piper Sandler maintained an Overweight rating and increased its price target to $169 from $160, signaling additional potential upside. Piper Sandler Rating and Price Target
• Neutral Sentiment: Teleflex declared a quarterly dividend of $0.34 per share, payable September 30 to shareholders of record August 14. The dividend provides ongoing shareholder returns, though its approximately 1% yield is unlikely to be a major short-term catalyst.
• Negative Sentiment: GAAP diluted EPS from continuing operations fell to $0.96 from $1.54 a year earlier, while adjusted EPS declined from $3.73. Teleflex also reported a negative net margin, which may be weighing on the stock despite the quarterly earnings beat. Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source